Kura Oncology, Inc.
KURA
$6.02
$0.071.18%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -198.84% | 64.68% | -7.02% | -2.65% | -15.75% |
| Total Depreciation and Amortization | 18.14% | -1.92% | 2.97% | -13.68% | 9.35% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -9.73% | 17.23% | 0.26% | -6.64% | 17.81% |
| Change in Net Operating Assets | -107.10% | 4,821.67% | 85.18% | 162.99% | -232.50% |
| Cash from Operations | -126.73% | 719.55% | -2.14% | 12.93% | -42.37% |
| Capital Expenditure | 21.51% | -- | 100.00% | 80.95% | -425.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -6.91% | -307.71% | 5.45% | 145.34% | -325.66% |
| Cash from Investing | -6.80% | -308.53% | 5.49% | 145.28% | -325.94% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -82.26% | -63.40% | -27.57% | -97.95% | 21,371.64% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -82.26% | -63.40% | -27.57% | -97.95% | 21,371.64% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -198.98% | 3,972.19% | 16.86% | -12.20% | -51.18% |